43 min ago | MediLexicon
Data Demonstrating Significant Efficacy Of Viread(R) In Treating...
Gilead Sciences, Inc. today announced the publication of detailed 48-week data from two Phase III pivotal clinical trials evaluating the safety and efficacy of its once-daily Viread for the treatment of chronic ...
Sanofi-Aventis to Cut U.S. Sales Jobs
French drugmaker Sanofi-Aventis SA is cutting an unspecified number of U.S. sales jobs as part of a realignment of its marketing.
Wall Street points to lower open
Wall Street headed toward a lower open Thursday on dismal retail sales reports and a spate of discouraging corporate news, including significant job cuts at AT&T and DuPont and a weaker-than-expected 2009 ...
Report: Measles deaths drop worldwide
Measles deaths worldwide declined dramatically to about 200,000 a year, continuing a successful trend, global health authorities reported Thursday.
Merck sets 2009 profit outlook below Wall Street estimates
Merck this morning said its 2009 profit will come in below Wall Street projections because of turmoil in the economy and challenges to some of its key drugs.
Advanced Life Sciences Announces Cethromycin NDA Accepted For Filing...
Main Category: Respiratory / Asthma Also Included In: Infectious Diseases / Bacteria / Viruses Clinical Trials / Drug Trials Advanced Life Sciences Holdings, Inc.
Introgen Therapeutics files for Chapter 11
Introgen Therapeutics Inc. , an Austin-based biopharmaceutical company that has most of its manufacturing operations in Houston, has filed for Chapter 11 bankruptcy protection and is looking to sell its ...
Novel bioreactor enhances interleukin-12 production in genetically-modified tobacco plants
Dec. 3, 2008 - Interleukin-12 is a naturally occurring protein essential for the proper functioning of the human immune system.
Dow unofficially ends up 180.64 points or 2.15 percent; S&P up 2.62 percent; Nasdaq up 2.94 percent.
Stocks rose on Wednesday as news pointing to a deepening recession spurred investors to buy defensive stocks, including the shares of biotechnology companies.
Wyeth Submits European Marketing Authorization Application For...
Main Category: Immune System / Vaccines Also Included In: Infectious Diseases / Bacteria / Viruses Wyeth Pharmaceuticals, a division of Wyeth , announced today that it has submitted a marketing authorization ...
Mattawan clinical research company cutting jobs
A Mattawan clinical research company that announced earlier this year a plan to add 3,300 new jobs says the economic downturn is forcing it to lay off some employees.
Alcon Cleared In Europe For Drop For Intraocular Pressure
Just as your pulse is checked during a routine physical, free cash flow is used as an indicator of a company's health.
National Institutes of Health (NIH) N...
New Data Provide Comprehensive Understanding of Americans' Use...
New Data Provide Comprehensive Understanding of Americans' Use of Complementary and Alternative Medicine What: The release of a nationwide government survey on trends and demographic use of complementary and ...
Next-Generation Noninvasive Diagnostic Technology Shown to Accurately ...
Sequenom, Inc. announced new data from a collaborative project with The Chinese University of Hong Kong, published this week in the Early Edition of the Proceedings of the National Academy of Sciences, that ...
Health Tip: Be Sure to Get a Flu Shot
The annual flu shot is recommended for most people, but certain people are at particularly high risk of contracting the nasty bug and its complications.
Quintiles acquires TMD for oncology
Quintiles acquires TMD for oncology : From staff reports Dec 2, 2008 DURHAM -- Quintiles Transnational Corp.
Paladin Labs, GSK Sign Dexedrine Pact
Paladin Labs has entered an agreement with GSK and Glaxo Group Ltd. under which Paladin will be the exclusive distributor of Dexedrine in Canada for three years, after which Paladin has the option to purchase ...
Genaera starts trial of Trodusquemine in overweight and obese type 2 diabetes
Genaera Corporation has announced that dosing of subjects has begun in study MSI-1436C-102 , the multiple ascending dose Phase 1b study of trodusquemine in overweight and obese type 2 diabetics.
FDA Approves Duramed's Synthetic Conjugated Estrogens-A Vaginal Cream
Barr Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has approved its subsidiary Duramed Pharmaceuticals, Inc.'s New Drug Application for Synthetic Conjugated Estrogens-A 0.625 ...
Hopes for AIDS vaccine still alive despite setbacks
Nobody said HIV would give up without a fight. As World AIDS Day arrives Dec. 1, scientists are taking a sobering look back at what went wrong in recent, high-profile failures of two human trials of candidate ...